Humana AB (publ) (HUM.ST) Research

Humana AB (publ), founded in 2001 and headquartered in Stockholm, Sweden, offers a wide range of individual and family care services across Sweden, Finland, Norway, and Denmark, serving both children and adults. The company's operations are divided into five core segments. The Individual & Family segment delivers comprehensive care and treatment for individuals experiencing psychosocial disorders, mental health conditions, and functional impairments. This includes residential care homes, interim and permanent family care placements, specialized residential solutions, outpatient services, assisted living facilities, specially adapted housing for individuals with functional impairments, and special education schools. The Personal Assistance segment provides dedicated support and assistance to individuals living with functional impairments. The Elderly Care segment specializes in residential care facilities for seniors. Its Finland segment offers individual and family care services for children, young people, and families dealing with psychiatric diagnoses or psychosocial disorders, alongside specialized housing for individuals with functional impairments, and both residential and day care for seniors. Finally, the Norway segment provides individual and family care, personal assistance, and specialized housing for individuals with functional impairments.

Market snapshot

Symbol
HUM.ST
Price
$44.70
Day change
-1.22%
Market cap
$2.1B
P/E ratio
11.06x
52-week range
32.7-56.6
Sector
Healthcare
Industry
Medical - Care Facilities
Next earnings
in 25 days

Peer companies

  • BICO Group AB (publ) (BICO.ST)
  • BioInvent International AB (publ) (BINV.ST)
  • Carasent AB (publ) (CARA.ST)
  • Devyser Diagnostics AB (publ) (DVYSR.ST)
  • Egetis Therapeutics AB (publ) (EGTX.ST)
  • Hansa Biopharma AB (publ) (HNSA.ST)
  • Implantica AG (IMP-A-SDB.ST)
  • Saniona AB (publ) (SANION.ST)

Open Humana AB (publ) (HUM.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.